Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South Africa
Background. Kaposi sarcoma (KS) is one of the most common neoplasms diagnosed in HIV-seropositive subjects. Oral involvement is frequent and is associated with a poor prognosis. The aim of this study was to characterize the features of oral HIV-KS in patients from Ga-Rankuwa, South Africa. Methods...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | AIDS Research and Treatment |
Online Access: | http://dx.doi.org/10.1155/2012/873171 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832551296403505152 |
---|---|
author | Razia A. G. Khammissa Liron Pantanowitz Liviu Feller |
author_facet | Razia A. G. Khammissa Liron Pantanowitz Liviu Feller |
author_sort | Razia A. G. Khammissa |
collection | DOAJ |
description | Background. Kaposi sarcoma (KS) is one of the most common neoplasms diagnosed in HIV-seropositive subjects. Oral involvement is frequent and is associated with a poor prognosis. The aim of this study was to characterize the features of oral HIV-KS in patients from Ga-Rankuwa, South Africa. Methods. All cases with confirmed oral HIV-KS treated at the oral medicine clinic in Ga-Rankuwa from 2004 to 2010 were included in this retrospective study. Differences between males and females with oral HIV-KS in relation to HIV infection status, to oral KS presentation and to survival rates were statistically analysed. Results. Twenty (54%) of the 37 patients in the study were females and 17 (46%) were males. In 21 patients (57%), the initial presentation of HIV-KS was in the mouth. Other than the fact that females presented with larger (≥10 mm) oral KS lesions (P=0.0004), there were no statistically significant gender differences. Significantly more patients presented with multiple oral HIV-KS lesions than with single lesions (P=0.0003). Nine patients (24%) developed concomitant facial lymphoedema, and these patients had a significantly lower CD4+ T-cell count (28 cells/mm3) compared to the rest of the group (130 cells/mm3) (P=0.01). The average CD4+ T-cell count of the patients who died (64 cells/mm3) was significantly lower (P=0.0004), there were no statistically significant gender differences. Significantly more patients presented with multiple oral HIV-KS lesions than with single lesions (P=0.016) at the time of oral-KS presentation than of those who survived (166 cells/mm3). Conclusions: In Ga-Rankuwa, South Africa where HIV-KS is prevalent, oral KS affects similarly males and females. A low CD4+ T-cell count at the time of oral HIV-KS diagnosis and the development of facial lymphoedema during the course of HIV-KS disease portends a poor prognosis. |
format | Article |
id | doaj-art-f87bc11f9e814f68a055572cc779db3b |
institution | Kabale University |
issn | 2090-1240 2090-1259 |
language | English |
publishDate | 2012-01-01 |
publisher | Wiley |
record_format | Article |
series | AIDS Research and Treatment |
spelling | doaj-art-f87bc11f9e814f68a055572cc779db3b2025-02-03T06:01:50ZengWileyAIDS Research and Treatment2090-12402090-12592012-01-01201210.1155/2012/873171873171Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South AfricaRazia A. G. Khammissa0Liron Pantanowitz1Liviu Feller2Department of Periodontology and Oral Medicine, University of Limpopo, Medunsa Campus, Pretoria 0204, South AfricaDepartment of Pathology, University of Pittsburgh Medical Centre, Pittsburgh, PA 15260, USADepartment of Periodontology and Oral Medicine, University of Limpopo, Medunsa Campus, Pretoria 0204, South AfricaBackground. Kaposi sarcoma (KS) is one of the most common neoplasms diagnosed in HIV-seropositive subjects. Oral involvement is frequent and is associated with a poor prognosis. The aim of this study was to characterize the features of oral HIV-KS in patients from Ga-Rankuwa, South Africa. Methods. All cases with confirmed oral HIV-KS treated at the oral medicine clinic in Ga-Rankuwa from 2004 to 2010 were included in this retrospective study. Differences between males and females with oral HIV-KS in relation to HIV infection status, to oral KS presentation and to survival rates were statistically analysed. Results. Twenty (54%) of the 37 patients in the study were females and 17 (46%) were males. In 21 patients (57%), the initial presentation of HIV-KS was in the mouth. Other than the fact that females presented with larger (≥10 mm) oral KS lesions (P=0.0004), there were no statistically significant gender differences. Significantly more patients presented with multiple oral HIV-KS lesions than with single lesions (P=0.0003). Nine patients (24%) developed concomitant facial lymphoedema, and these patients had a significantly lower CD4+ T-cell count (28 cells/mm3) compared to the rest of the group (130 cells/mm3) (P=0.01). The average CD4+ T-cell count of the patients who died (64 cells/mm3) was significantly lower (P=0.0004), there were no statistically significant gender differences. Significantly more patients presented with multiple oral HIV-KS lesions than with single lesions (P=0.016) at the time of oral-KS presentation than of those who survived (166 cells/mm3). Conclusions: In Ga-Rankuwa, South Africa where HIV-KS is prevalent, oral KS affects similarly males and females. A low CD4+ T-cell count at the time of oral HIV-KS diagnosis and the development of facial lymphoedema during the course of HIV-KS disease portends a poor prognosis.http://dx.doi.org/10.1155/2012/873171 |
spellingShingle | Razia A. G. Khammissa Liron Pantanowitz Liviu Feller Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South Africa AIDS Research and Treatment |
title | Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South Africa |
title_full | Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South Africa |
title_fullStr | Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South Africa |
title_full_unstemmed | Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South Africa |
title_short | Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South Africa |
title_sort | oral hiv associated kaposi sarcoma a clinical study from the ga rankuwa area south africa |
url | http://dx.doi.org/10.1155/2012/873171 |
work_keys_str_mv | AT raziaagkhammissa oralhivassociatedkaposisarcomaaclinicalstudyfromthegarankuwaareasouthafrica AT lironpantanowitz oralhivassociatedkaposisarcomaaclinicalstudyfromthegarankuwaareasouthafrica AT liviufeller oralhivassociatedkaposisarcomaaclinicalstudyfromthegarankuwaareasouthafrica |